Edine W. Tiemersma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Edine W. Tiemersma has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Hajo Grundmann
National Institute for Public Health and the Environment, Bilthoven, The Netherlands
2 shared publicationsNienke Bruinsma
National Institute for Public Health and the Environment, Bilthoven, The Netherlands
2 shared publicationsDominique L Monnet
Statens Serum Institut, Copenhagen, Denmark
1 shared publicationEuropean Antimicrobial Resistance Surveillance System Participants
1 shared publicationJohn E. Degener
University Hospital Groningen, Groningen, The Netherlands
1 shared publicationJos C M Monen
National Institute for Public Health and the Environment, Bilthoven, The Netherlands
1 shared publication
Latest Publications
- Open Access
- 1 November 2005
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 11 (11) , 1798-1799
Staphylococcus aureusBacteremia, Europe
- 1 November 2005
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 11 (11) , 1798-1799
Open AccessStaphylococcus aureusBacteremia, Europe
- Open Access
- 1 September 2004
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 10 (9) , 1627-1634
Methicillin-resistantStaphylococcus aureusin Europe, 1999–2002
We explored the variation in proportions of methicillin-resistant Staphylococcus aureus (MRSA) between and within countries participating in the European Antimicrobial Resistance Surveillance System and temporal trends in its occurrence. This system collects routine antimicrobial susceptibility tests for S. aureus. We examined data collected from January 1999 through December 2002 (50,759 isolates from 495 hospitals in 26 countries). MRSA prevalence varied almost 100-fold, from 40% in southern and western Europe. MRSA proportions significantly increased in Belgium, Germany, Ireland, the Netherlands, and the United Kingdom, and decreased in Slovenia. Within countries, MRSA proportions varied between hospitals with highest variance in countries with a prevalence of 5% to 20%. The observed trends should stimulate initiatives to control MRSA at national, regional, and hospital levels. The large differences between hospitals indicate that efforts may be most effective at regional and hospital levels.
- 1 September 2004
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 10 (9) , 1627-1634
Open AccessMethicillin-resistantStaphylococcus aureusin Europe, 1999–2002
We explored the variation in proportions of methicillin-resistant Staphylococcus aureus (MRSA) between and within countries participating in the European Antimicrobial Resistance Surveillance System and temporal trends in its occurrence. This system collects routine antimicrobial susceptibility tests for S. aureus. We examined data collected from January 1999 through December 2002 (50,759 isolates from 495 hospitals in 26 countries). MRSA prevalence varied almost 100-fold, from 40% in southern and western Europe. MRSA proportions significantly increased in Belgium, Germany, Ireland, the Netherlands, and the United Kingdom, and decreased in Slovenia. Within countries, MRSA proportions varied between hospitals with highest variance in countries with a prevalence of 5% to 20%. The observed trends should stimulate initiatives to control MRSA at national, regional, and hospital levels. The large differences between hospitals indicate that efforts may be most effective at regional and hospital levels.